发明名称 SURROGATE THERAPEUTIC ENDPOINT FOR ANTI-CTLA-4 BASED IMMUNOTHERAPY OF DISEASE
摘要 The present invention provides a method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.
申请公布号 ZA200510125(B) 申请公布日期 2006.12.27
申请号 ZA20050010125 申请日期 2005.12.13
申请人 E. R. SQUIBB & SONS, L.L.C. 发明人 LOWY ISRAEL;NICHOL GEOFFREY M
分类号 C07K;A61K;C07K16/28;G01N33/574 主分类号 C07K
代理机构 代理人
主权项
地址